| Vol. 6.10 – 22 March, 2021 |
| |
|
|
| To identify mechanisms and cardio-protective drugs, scientists used a state-of-the-art pipeline combining human cardiac organoids with phosphoproteomics and single nuclei RNA sequencing. [Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| | Epicardial-derived cardiac fibroblasts and epithelial cells expressed paracrine factors, including TGFβ1 and FGFs, which mediated epithelial-to-mesenchymal transition, and contributed to the pathogenesis of myocardial fibrosis, apoptosis, arrhythmias, and cardiac dysfunction in a mouse model of arrhythmogenic cardiomyopathy. [Circulation] |
|
|
|
| Scientists developed a unique automated template matching cardiomyocyte beating model to achieve arrhythmic recognition at the single beat level with an interdigitated electrode impedance detection system. [Microsystems & Nanoengineering] |
|
|
|
| Researchers describe an assay platform by coupling human-iPSC-CMs and impedance measurement, which allowed real-time monitoring of cardiomyocyte cellular index, beating amplitude, and beating rate. [The AAPS Journal] |
|
|
|
| Investigators hypothesized that coating of 3D cardiac tissue-derived hiPSC-CMs with the extracellular matrix protein fibronectin would improve the survival of transplanted cells in the heart and improve heart function in a rat model of ischemic heart failure. [PLOS ONE] |
|
|
|
|
| Scientists showed that myogenic stem cells, led to functional muscle regeneration in the three animal models. [Nature Biomedical Engineering] |
|
|
|
| The authors performed a longitudinal comparison of the transcriptomic profiles of three human induced pluripotent stem cell lines that displayed differential myogenic specification, one robust and two blunted. [Science Advances] |
|
|
|
| Through a muscle-stem-cell-specific deletion, investigators showed that negative elongation factor was required for efficient muscle regeneration and stem cell pool replenishment. [Developmental Cell] |
|
|
|
| Scientists suggested that CREG1 deficiency accelerated the induction of mitophagy in the skeletal muscle. Mechanistically, gain-and loss-of-function mutations of Creg1 altered mitochondrial morphology and function, impairing mitophagy in C2C12 cells. [Autophagy] |
| |
|
|
| Immuno-RNA fluorescence in situ hybridization validated loss of Tspan2 in vascular smooth muscle cells of homology-directed repair and prime editing 2 CArG box mutant mice. [Genome Biology] |
|
|
|
| Researchers showed that 17β‐estradiol‐induced mitochondrial autophagy played a crucial role in the delay of vascular senescence. [Journal of the American Heart Association] |
|
|
|
| Scientists analyzed the expression of circRNAs at the adult and embryo development stages of cattle musculus longissimus. A stringent set of 1,319 circRNAs candidates were identified, and found that 495 circRNAs were differentially expressed between embryonic and adult tissues libraries. [Molecular Therapy-Nucleic Acids] |
| |
|
|
|
| Investigators discuss recent progress in overcoming the hurdles that should facilitate the use of human induced pluripotent stem cells (iPSC) to develop new medicines and individualize therapies for heart disease. [Cell Chemical Biology] |
|
|
|
| Scientists explore the emerging evidence that supports novel and important roles for the POU4F2/Brn-3b transcription factor in controlling cellular genes that regulate cardiometabolic function. [Cell Death & Disease] |
|
|
|
| The authors discuss the key drug-protein interactions known to be involved in cardiotoxic drug response. [Cell Reports Medicine] |
|
|
|
|
| The SMA Foundation and PTC Therapeutics, Inc. have entered into a new collaboration focused on regenerative medicine to further advance scientific research in SMA and other neuromuscular disorders with the goal of developing new treatments. [The Spinal Muscular Atrophy Foundation] |
|
|
|
| FibroGen, Inc. announced the initiation of LELANTOS-2, a Phase III, randomized, double-blind, placebo-controlled trial of pamrevlumab or placebo in combination with systemic corticosteroids in patients with ambulatory Duchenne muscular dystrophy. [FibroGen, Inc.] |
|
|
|
|
| March 22 – 24, 2021 Virtual |
|
|
|
|
|
|
| University of Southern Denmark – Odense M, Denmark |
|
|
|
| Mount Sinai Health System – New York, New York, United States |
|
|
|
| University of Southern Denmark – Odense M, Denmark |
|
|
|
| Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
|